Drugs / Reference IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT03092791 Comparator | Jun 2017 → Apr 2018 | poliomyelitis | Takeda | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Reference IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03092791 ↗ |
| Route | Intramuscular | “Reference IPV intramuscular injection” NCT03092791 ↗ |